DENALI THERAPEUTICS INC's ticker is DNLI and the CUSIP is 24823R105. A total of 186 filers reported holding DENALI THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.37 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $27,889,697 | -11.1% | 1,351,900 | +27.1% | 0.07% | -5.1% |
| Q2 2023 | $31,383,885 | +28.1% | 1,063,500 | 0.0% | 0.08% | +25.8% |
| Q1 2023 | $24,503,040 | +13.7% | 1,063,500 | +37.2% | 0.06% | +3.3% |
| Q4 2022 | $21,552,750 | +7.0% | 775,000 | +18.0% | 0.06% | +1.7% |
| Q3 2022 | $20,151,000 | +2.4% | 656,593 | -1.8% | 0.06% | +9.3% |
| Q2 2022 | $19,687,000 | -32.4% | 668,929 | -26.1% | 0.05% | -18.2% |
| Q1 2022 | $29,122,000 | -11.2% | 905,245 | +23.1% | 0.07% | +8.2% |
| Q4 2021 | $32,800,000 | +91.7% | 735,432 | +116.8% | 0.06% | +84.8% |
| Q3 2021 | $17,110,000 | +57.3% | 339,160 | +144.6% | 0.03% | +65.0% |
| Q2 2021 | $10,874,000 | +46.5% | 138,632 | +6.7% | 0.02% | +42.9% |
| Q1 2021 | $7,421,000 | -62.2% | 129,960 | -44.5% | 0.01% | -65.0% |
| Q4 2020 | $19,617,000 | +327.1% | 234,200 | +82.7% | 0.04% | +263.6% |
| Q3 2020 | $4,593,000 | -31.5% | 128,195 | -53.8% | 0.01% | -35.3% |
| Q2 2020 | $6,709,000 | +211.5% | 277,463 | +167.4% | 0.02% | +240.0% |
| Q2 2019 | $2,154,000 | -9.9% | 103,755 | +0.8% | 0.01% | -16.7% |
| Q1 2019 | $2,390,000 | – | 102,922 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Crestline Management, LP | 7,705,039 | $343,645,000 | 25.68% |
| Casdin Capital, LLC | 1,500,000 | $66,900,000 | 1.89% |
| Flagship Pioneering Inc. | 2,619,968 | $116,851,000 | 1.81% |
| SECTORAL ASSET MANAGEMENT INC | 189,600 | $8,456,000 | 1.27% |
| Integral Health Asset Management, LLC | 100,000 | $4,460,000 | 1.23% |
| Temasek Holdings (Private) Ltd | 5,369,487 | $239,479,000 | 0.86% |
| Goldstream Capital Management Ltd | 78,418 | $3,497,000 | 0.86% |
| Yiheng Capital Management, L.P. | 335,184 | $14,949,000 | 0.76% |
| GILDER GAGNON HOWE & CO LLC | 2,900,114 | $129,345,000 | 0.74% |
| Artal Group S.A. | 600,000 | $26,760,000 | 0.73% |